PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1279853
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1279853
Global Submucosal Injections Market is valued at approximately USD 1.23 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.8% over the forecast period 2023-2030. Submucosal injection is a medical technique that involves injecting drugs or other therapeutic substances into a tissue or organ's submucosal layer. The submucosal layer is the layer of tissue that lies just below the mucous membrane, which lines the inner surface of various organs, such as the gastrointestinal tract, respiratory tract, and urinary tract. Submucosal injections are commonly used in medical and surgical procedures for diagnostic, therapeutic, or palliative purposes. The rising incidences of cancer, the surge in the number of endoscopic mucosal resection procedures, increasing favorable reimbursement policies, and the development of the healthcare sector are the key driving factors for market growth across the globe.
In addition, the rising preference towards minimally invasive procedures is playing a vital role in stipulating market growth across the globe. Submucosal injections are minimally invasive procedures that offer advantages such as reduced postoperative complications, faster recovery, and shorter hospital stays. According to Statista, the worldwide revenue for minimally invasive surgery reached around USD 20.5 billion in 2019. This amount is also anticipated to increase and is expected to reach about USD 44.04 billion by 2030. As the trend towards minimally invasive procedures continues to gain traction, the demand for submucosal injections as part of these procedures is expected to increase during the estimated period. Moreover, the rising adoption of advanced technology in healthcare, as well as the rising focus on early diagnosis and intervention present various lucrative opportunities over the forecasting years. However, the unavailability of skilled healthcare professionals and the presence of alternative treatment options are challenging the market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Submucosal Injections Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising endoscopic mucosal resection procedures, and the presence of well-established healthcare facilities. Whereas, Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as favorable government initiatives, increasing healthcare expenditure, and Increased application of submucosal injections in the market space.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable